Prostate volume, LUTS scale, and uroflowmetry of benign prostate hyperplasia patients with type 2 diabetes mellitus

Introduction . Benign prostate hyperplasia (BPH) is an enlargement of the prostate due to abnormal proliferation or apoptosis failure of the epithelial or stroma tissues. Objective . To compare the prostate volume, IPSS score (LUTS scale), and uroflowmetry of BPH patients with type 2 diabetes mellitus. Materials & Methods . The medical records of BPH patients from 2011 to 2015 were assessed with an analytical retrospective study based on the prostate volume, IPSS score (LUTS scale), and Q max using uroflowmetry. The data were analyzed using the chi-square test by online statistical analysis. Results . Among 62 patients recorded, 11 patients were diabetic, while the rest were non-diabetic. No notable differences were observed between the two groups (p > 0.05) in prostate volume, IPSS score, and Q max. Conclusion . No significant differences in prostate volume, IPSS score (LUTS scale), and uroflowmetry between diabetic and non-diabetic BPH patients.